22nd week of 2018 patent applcation highlights part 19 |
Patent application number | Title | Published |
20180148417 | Production Method of Enzalutamide Crystal Form | 2018-05-31 |
20180148418 | AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES | 2018-05-31 |
20180148419 | BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS | 2018-05-31 |
20180148420 | NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME | 2018-05-31 |
20180148421 | Hybrid Scorch Retardant/Cure Co-Agent | 2018-05-31 |
20180148422 | FORMULATION OF METAXALONE | 2018-05-31 |
20180148423 | Process for Preparing (E)-(5,6-Dihydro-1,4,2-Dioxazine-3-YL) (2-Hydroxyphenyl) Methanone O-Methyl Oxime | 2018-05-31 |
20180148424 | METHOD FOR PRODUCING DICARBOXYLIC ACID COMPOUND | 2018-05-31 |
20180148425 | N-ARALKYLCARBONYL-PIPERAZINE AND -HOMOPIPERAZINE COMPOUNDS AND PERSONAL CARE COMPOSITIONS COMPRISING THE SAME | 2018-05-31 |
20180148426 | EPOXIDATION USING PEROXYGENASE | 2018-05-31 |
20180148427 | PHENOL DERIVATIVES TO TREAT CANCER | 2018-05-31 |
20180148428 | ORGANIC LIGHT EMITTING DEVICE WITH THERMALLY ACTIVATED DELAYED FLUORESCENT LIGHT EMITTING MATERIAL | 2018-05-31 |
20180148429 | SUBSTITUTED QUINOXALINE DERIVATIVES | 2018-05-31 |
20180148430 | METHOD FOR PREPARING NILOTINIB | 2018-05-31 |
20180148431 | 2-H-INDAZOLE DERIVATIVES AS CYCLIN-DEPENDENT KINASE (CDK) INHIBOTORS AND THERAPEUTIC USES THEREOF | 2018-05-31 |
20180148433 | New Pyrazolyl-substituted Heteroaryls and their use as Medicaments | 2018-05-31 |
20180148434 | Novel 16-member triamilide derivatives and uses thereof | 2018-05-31 |
20180148435 | 4-AMINOQUINAZOLIN COMPOUNDS AS PROLYL HYDROXYLASE INHIBITORS | 2018-05-31 |
20180148436 | PYRIDONE DERIVATIVES HAVING TETRAHYDROPYRANYLMETHYL GROUPS | 2018-05-31 |
20180148437 | Novel Ezrin Inhibitors and Methods of Making and Using | 2018-05-31 |
20180148438 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | 2018-05-31 |
20180148439 | DEUTERATED O-SULFATED BETA LACTAM HYDROXAMIC ACIDS AND DEUTERATED N-SULFATED BETA LACTAMS | 2018-05-31 |
20180148440 | SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS | 2018-05-31 |
20180148441 | Cycloalkyl-Linked Diheterocycle Derivatives | 2018-05-31 |
20180148442 | Polycyclic Indoline and Indolenine Compounds | 2018-05-31 |
20180148443 | CRYSTALS OF AZABICYCLIC COMPOUND | 2018-05-31 |
20180148444 | 2-(1H-INDAZOL-3-YL)-3H-IMIDAZO[4,5-B]PYRIDINE AND THERAPEUTIC USES THEREOF | 2018-05-31 |
20180148445 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | 2018-05-31 |
20180148446 | PYRROLO [2,3-c] PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE | 2018-05-31 |
20180148447 | PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE | 2018-05-31 |
20180148448 | -LACTAMASE INHIBITORS AND USES THEREOF | 2018-05-31 |
20180148449 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the Uses Thereof | 2018-05-31 |
20180148450 | TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS | 2018-05-31 |
20180148451 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | 2018-05-31 |
20180148452 | TOLL-LIKE RECEPTOR-7 AGONIST | 2018-05-31 |
20180148453 | DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | 2018-05-31 |
20180148454 | USE OF PTERIDINONE DERIVATIVE SERVING AS EGFR INHIBITOR | 2018-05-31 |
20180148455 | NOVEL TLR2 ANTAGONISTS | 2018-05-31 |
20180148456 | NOTCH PATHWAY SIGNALING INHIBITOR COMPOUNDS | 2018-05-31 |
20180148457 | FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS | 2018-05-31 |
20180148458 | TETRAHYDROISOQUINOLINE DERIVATIVES | 2018-05-31 |
20180148459 | 4-((2-ACRYLAMIDOPHENYL)AMINO)THIENO[3,2-D]PYRIMIDINE-7-CARBOXAMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS | 2018-05-31 |
20180148460 | TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS | 2018-05-31 |
20180148461 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | 2018-05-31 |
20180148462 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | 2018-05-31 |
20180148463 | Novel Prodrugs And Methods Of Use Thereof | 2018-05-31 |
20180148464 | TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES | 2018-05-31 |
20180148465 | PROCESS | 2018-05-31 |
20180148466 | Precursors For Deposition Of Metal, Metal Nitride And Metal Oxide Based Films Of Transition Metals | 2018-05-31 |
20180148467 | A METHOD AND AN APPARATUS FOR WASHING A CRUDE LIGNIN, A SOLUBLE CARBOHYDRATE CONTAINING FRACTION, A SOLID FRACTION AND THEIR USE | 2018-05-31 |
20180148468 | USE OF UAP INHIBITORS TO INHIBIT FLUX THROUGH THE HEXOSAMINE BIOSYNTHETIC PATHWAY | 2018-05-31 |
20180148469 | PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES | 2018-05-31 |
20180148470 | CHOLIC ACID DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF | 2018-05-31 |
20180148471 | METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION | 2018-05-31 |
20180148472 | AFFINITY-ASSISTED PROTEIN MODIFICATION AND RECYCLING | 2018-05-31 |
20180148473 | PROCESS FOR PREPARATION OF NITROGEN MUSTARD DERIVATIVES | 2018-05-31 |
20180148474 | PEPTIDE DERIVATIVE FOR REGULATING THYMIC STROMAL LYMPHOID PROTEIN-MEDIATED SIGNALING AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ALLERGY AND ASTHMA DISEASES COMPRISING SAME | 2018-05-31 |
20180148475 | Cardiovascular Therapeutics | 2018-05-31 |
20180148476 | Compositions for Colon Cleansing and the Treatment of Gastrointestinal Disorders | 2018-05-31 |
20180148477 | NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS | 2018-05-31 |
20180148478 | Melanocortin Receptor-Specific Peptide with C-Terminal Naphthylalanine | 2018-05-31 |
20180148479 | MULTITARGET-DIRECTED BIO-INORGANIC HYBRID STRUCTURE | 2018-05-31 |
20180148480 | SYNTHETIC ENHANCEMENT OF THE T-CELL ARMAMENTARIUM AS AN ANTI-CANCER THERAPY | 2018-05-31 |
20180148481 | MUTANT CSGG PORES | 2018-05-31 |
20180148482 | Toxoid Peptides Derived From Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof | 2018-05-31 |
20180148483 | Mu-Conotoxin Peptides And Use Thereof As A Local Anesthetic | 2018-05-31 |
20180148484 | NOVEL PROTEINS SPECIFIC FOR CD137 | 2018-05-31 |
20180148485 | ANTI-CANCER FUSION POLYPEPTIDE | 2018-05-31 |
20180148486 | HUMAN CELL LINES MUTANT FOR ZIC2 | 2018-05-31 |
20180148487 | NOVEL TLR4 ANTAGONIST | 2018-05-31 |
20180148488 | NOVEL MICRO-DYSTROPHINS AND RELATED METHODS OF USE | 2018-05-31 |
20180148489 | IDR PEPTIDE COMPOSITIONS AND USE THEREOF FOR TREATMENT OF TH2-DYSREGULATED INFLAMMATORY CONDITIONS | 2018-05-31 |
20180148490 | MONOMERIC CXCL121 PEPTIDE AND USE THEREOF | 2018-05-31 |
20180148491 | Novel Hybrid ActRIIB Ligand Trap Proteins For Treating Muscle Wasting Diseases | 2018-05-31 |
20180148492 | CDH26 BASED THERAPEUTIC AGENTS AND THEIR USE | 2018-05-31 |
20180148493 | HIV VPR-SPECIFIC T-CELL RECEPTORS | 2018-05-31 |
20180148494 | SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS | 2018-05-31 |
20180148495 | VARIANT FACTOR VIII POLYPEPTIDES AND METHODS OF THEIR PRODUCTION AND USE | 2018-05-31 |
20180148496 | ANTI-PRE-S1 HBV ANTIBODIES | 2018-05-31 |
20180148497 | BISPECIFIC MOLECULES COMPRISING AN HIV-1 ENVELOPE TARGETING ARM | 2018-05-31 |
20180148498 | FUNGAL DETECTION USING MANNAN EPITOPE | 2018-05-31 |
20180148499 | Antibody Therapy for Amyloid Beta Disease | 2018-05-31 |
20180148500 | METHODS OF SHIFTING AN ISOELECTRIC PROFILE OF A PROTEIN PRODUCT AND USES THEREOF | 2018-05-31 |
20180148501 | TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF | 2018-05-31 |
20180148502 | Antibodies against phosphorylcholine in combination therapy with biologic agents | 2018-05-31 |
20180148503 | T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR A PRAME PEPTIDE | 2018-05-31 |
20180148504 | Anti-Folate Receptor Alpha Antibodies And Uses Thereof | 2018-05-31 |
20180148505 | LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS | 2018-05-31 |
20180148506 | BLOCKADE OF CD7 EXPRESSION AND CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY OF T-CELL MALIGNANCIES | 2018-05-31 |
20180148507 | METHODS OF USING BISPECIFIC CD33 AND CD3 BINDING PROTEINS | 2018-05-31 |
20180148508 | MASKING CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TUMOR-SPECIFIC ACTIVATION | 2018-05-31 |
20180148509 | COMPOSITION FOR TREATING IL-6-RELATED DISEASES | 2018-05-31 |
20180148510 | PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA | 2018-05-31 |
20180148511 | OPTIMIZED ANTIBODIES THAT TARGET CD19 | 2018-05-31 |
20180148512 | FUSION PROTEINS THAT FACILITATE CANCER CELL DESTRUCTION | 2018-05-31 |
20180148513 | ANTI-PD-1 ANTIBODIES AND THEIR USES | 2018-05-31 |
20180148514 | MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF | 2018-05-31 |
20180148515 | METHOD FOR PREPARING A CELLULOSE SPONGE | 2018-05-31 |
20180148516 | Cellulosic Arabinoxylan fiber (CAF) and Methods of Preparing | 2018-05-31 |
20180148517 | Bulk Polymerization of Silicone-Containing Copolymers | 2018-05-31 |